Background Angiotensin-converting–enzyme (ACE) inhibitors are effective in reducing the
risk of heart failure, myocardial infarction, and death from cardiovascular causes in patients …

Background Results of randomized trials of angiotensin-converting enzyme inhibitors in
patients with coronary artery disease (CAD) and preserved left ventricular function are …

Objectives: This study sought to assess the efficacy of angiotensin-converting enzyme
inhibitors (ACEIs) in patients with coronary heart disease and preserved left ventricular (LV) …

The development of angiotensin-converting enzyme inhibitors (ACE inhibitors) has been
one of the most remarkable stories in the treatment of cardiovascular diseases. Angiotensin …

Angiotensin-converting enzyme (ACE) inhibitors appear to possess unique cardioprotective
benefits, even when used in patients without high blood pressure or left ventricular …

Background Angiotensin-converting-enzyme (ACE) inhibitors reduce cardiovascular
mortality and morbidity in patients with heart failure or left ventricular systolic dysfunction …

The Prevention of Events with Angiotensin-Converting Enzyme Inhibition (PEACE) trial is an
8,100 patient, randomized, double-blind, placebo-controlled trial designed to determine the …

A ngiotensin-converting enzyme (ACE) inhibitors are commonly used drugs in the
management of a variety of cardiovascular diseases. They are effective antihypertensive …

This study was conducted to provide evidence of an association between angiotensin-
converting enzyme (ACE) inhibitor use and clinical outcomes among patients with …

Proven cardiovascular benefit from angiotensin-converting enzyme (ACE) inhibition is a
cornerstone of evidence-based medicine. The first study to show dramatic benefits from ACE …